272 related articles for article (PubMed ID: 27790045)
1. Optimal management of dactylitis in patients with psoriatic arthritis.
Yamamoto T
Open Access Rheumatol; 2015; 7():55-62. PubMed ID: 27790045
[TBL] [Abstract][Full Text] [Related]
2. Psoriatic arthritis: from a dermatological perspective.
Yamamoto T
Eur J Dermatol; 2011; 21(5):660-6. PubMed ID: 21715249
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and inflammatory properties of psoriatic arthritis.
Yamamoto T
ISRN Dermatol; 2013; 2013():630620. PubMed ID: 23819059
[TBL] [Abstract][Full Text] [Related]
4. Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis.
Siegel EL; Orbai AM; Ritchlin CT
Curr Opin Rheumatol; 2015 Mar; 27(2):111-7. PubMed ID: 25603036
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of psoriatic arthritis.
Stober C
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101694. PubMed ID: 34108102
[TBL] [Abstract][Full Text] [Related]
6. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I; Macchioni P; Niccoli L; Padula A; Ferri S; Portioli I
J Rheumatol; 1997 Jun; 24(6):1106-10. PubMed ID: 9195517
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL).
Kavanaugh A; Mease P
J Rheumatol Suppl; 2012 Jul; 89():90-3. PubMed ID: 22751603
[TBL] [Abstract][Full Text] [Related]
8. High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis.
Tan AL; Fukuba E; Halliday NA; Tanner SF; Emery P; McGonagle D
Ann Rheum Dis; 2015 Jan; 74(1):185-9. PubMed ID: 25261575
[TBL] [Abstract][Full Text] [Related]
9. 'Deep Koebner' phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis.
Tinazzi I; McGonagle D; Aydin SZ; Chessa D; Marchetta A; Macchioni P
Ann Rheum Dis; 2018 Jun; 77(6):922-925. PubMed ID: 29511028
[TBL] [Abstract][Full Text] [Related]
10. Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis.
Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M
J Rheumatol; 2018 Nov; 45(11):1526-1531. PubMed ID: 29961685
[TBL] [Abstract][Full Text] [Related]
11. Differentiating psoriatic arthritis sine psoriasis from seronegative rheumatoid arthritis-Experiences from five patients.
Wang Q; Zhang H; Dai SM
Int J Rheum Dis; 2022 Sep; 25(9):1088-1092. PubMed ID: 35796066
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
13. Enthesitis in psoriatic arthritis.
Sakkas LI; Alexiou I; Simopoulou T; Vlychou M
Semin Arthritis Rheum; 2013 Dec; 43(3):325-34. PubMed ID: 23731532
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic Arthritis: What is Happening at the Joint?
Belasco J; Wei N
Rheumatol Ther; 2019 Sep; 6(3):305-315. PubMed ID: 31102105
[TBL] [Abstract][Full Text] [Related]
15. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
Torres T; Faria R
Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
[TBL] [Abstract][Full Text] [Related]
16. Immunologic advances reveal new targets in psoriasis and psoriatic arthritis.
Mortezavi M; Ritchlin C
Discov Med; 2015 Oct; 20(110):169-75. PubMed ID: 26562469
[TBL] [Abstract][Full Text] [Related]
17. Dactylitis: A hallmark of psoriatic arthritis.
Kaeley GS; Eder L; Aydin SZ; Gutierrez M; Bakewell C
Semin Arthritis Rheum; 2018 Oct; 48(2):263-273. PubMed ID: 29573849
[TBL] [Abstract][Full Text] [Related]
18. Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.
Toussirot E
Expert Opin Biol Ther; 2018 Jan; 18(1):101-107. PubMed ID: 29187009
[TBL] [Abstract][Full Text] [Related]
19. Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
Gladman DD; Orbai AM; Klitz U; Wei JC; Gallo G; Birt J; Rathmann S; Shrom D; Marzo-Ortega H
Arthritis Res Ther; 2019 Jan; 21(1):38. PubMed ID: 30696483
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography in the diagnosis and management of psoriatic dactylitis.
Kane D; Greaney T; Bresnihan B; Gibney R; FitzGerald O
J Rheumatol; 1999 Aug; 26(8):1746-51. PubMed ID: 10451072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
